Magnesium Glycinate vs Citrate vs Oxide UK Guide

Quick answer: Bioavailability differences between magnesium forms are real but smaller than marketing suggests. Oxide is the cheapest and least absorbed (~4% in some studies); citrate, bisglycinate, malate and taurate are better absorbed but cost more per gram of elemental magnesium. For most UK shoppers, the form your gut tolerates and that you will actually take consistently matters more than chasing the most-marketed chelate. The total daily elemental magnesium dose, kept inside UK reference intakes and the EU SCF supplemental upper limit, matters more than the form on the label.

What “elemental magnesium” actually means

Magnesium never appears on a supplement shelf as the bare metal. It is always bound to something — oxygen (in oxide), citric acid (in citrate), the amino acid glycine (in bisglycinate), malic acid (in malate), and so on. The compound on the label has a total mass that includes both the magnesium ion and the carrier. The amount of magnesium your body can actually use is called the elemental magnesium content.

This matters because two products labelled “magnesium 1,000 mg” can deliver wildly different amounts of elemental magnesium:

Magnesium oxide — about 60% elemental magnesium by mass.
Magnesium citrate — about 11–16% elemental magnesium by mass (depending on hydration state).
Magnesium bisglycinate — about 11–14% elemental magnesium by mass.
Magnesium malate — about 6–15% elemental magnesium by mass.
Magnesium L-threonate — about 8% elemental magnesium by mass.

A well-made label will state both the compound mass and the elemental magnesium amount per serving (for example, “Magnesium bisglycinate 1,000 mg, providing 100 mg elemental magnesium”). A label that prints only the headline compound milligrams is leaving the most useful number off the pack.

The UK NHS Reference Nutrient Intake (RNI) for magnesium is 300 mg/day for men and 270 mg/day for women. The EU SCF Tolerable Upper Intake Level for magnesium added through supplements (separate from food) is 250 mg/day. The 400 mg “RDA” figure that often appears on imported labels is the US Recommended Dietary Allowance, not the UK or EU value.

The five forms you’ll see on UK shelves

Magnesium oxide

The cheapest and most-bottled form. Oxide carries the highest elemental percentage by mass — around 60% — which is why a label can print a high “magnesium” milligram figure without using much actual compound. The trade-off is absorption: in the Firoz & Graber 2001 study of US commercial preparations, magnesium oxide showed fractional absorption of about 4%, well below magnesium chloride, lactate, and aspartate, which were “significantly higher and equivalent” to one another. Lindberg 1990 reached the same conclusion when comparing oxide head-to-head against citrate.

Oxide is widely used in clinical practice as a laxative (the unabsorbed magnesium pulls water into the bowel by osmosis) — which is also why it commonly causes loose stools at supplemental doses. As a deliberate supplement to top up dietary intake, the unabsorbed fraction is the main argument against it.

Magnesium citrate

Mid-priced, well-absorbed, widely available. The Walker 2003 randomised double-blind trial in 46 healthy adults compared citrate, an amino-acid chelate, and oxide at 300 mg elemental magnesium per day for 60 days, and reported magnesium citrate as the most bioavailable of the three on 24-hour urinary magnesium excretion. Lindberg 1990 also found citrate more soluble and more bioavailable than oxide.

Citrate has a mild laxative effect at higher doses (and is sold deliberately as a laxative in higher-dose preparations). For routine daily supplementation at 200–400 mg elemental magnesium, citrate is a reasonable default — affordable, well-absorbed, and predictable. Bowel sensitivity is the typical reason people switch off it.

Magnesium bisglycinate (also sold as glycinate)

A chelated form — the magnesium ion is bound to two molecules of the amino acid glycine. Generally regarded as well-absorbed and gentle on the gut, with less laxative effect than citrate at comparable elemental doses. This is the form most often marketed for sleep and “calm”.

Whether bisglycinate specifically improves sleep is less settled than the marketing implies. The Mah & Pitre 2021 systematic review and meta-analysis in BMC Complementary Medicine and Therapies pooled three small randomised trials in older adults and reported sleep onset latency reduced by about 17 minutes versus placebo, with no statistically significant change in total sleep duration. The authors themselves concluded that “the quality of literature is substandard for physicians to make well-informed recommendations”. The frequently-cited Abbasi 2012 trial (n=46 older adults with primary insomnia, 500 mg/day for 8 weeks) showed improvements on subjective sleep measures, but is small, single-centre, and not specifically a bisglycinate trial. There is no GB-authorised health claim that magnesium aids sleep — that wording would be unauthorised on a UK label.

Where bisglycinate clearly wins is bowel tolerance: people who don’t get on with citrate often do fine on bisglycinate at the same elemental dose. That’s a genuine reason to pay the premium if cost is acceptable.

Magnesium malate

Magnesium bound to malic acid (a Krebs-cycle intermediate). Bioavailability is roughly comparable to other chelated forms in the limited head-to-head data available. Malate is sometimes marketed for fatigue or fibromyalgia on the basis of a small number of older trials — the evidence is weak and there is no UK-authorised health claim for either indication. As a general-purpose well-absorbed magnesium it is reasonable; the fibromyalgia framing should be treated as marketing rather than evidence.

Magnesium taurate, threonate, and sulfate

Taurate — magnesium chelated with the amino acid taurine. Marketed for cardiovascular support; the human-trial evidence is thin and not specific enough to support a clinical claim. Generally well-tolerated.

L-threonate — the most expensive form on most UK shelves, marketed for brain and cognitive function. The original Slutsky et al. 2010 paper in Neuron was a rat study showing that magnesium L-threonate raised brain magnesium and improved learning and memory tasks in rats; this is the foundation citation that almost all consumer marketing rests on. The most-cited human evidence is Liu et al. 2016 in the Journal of Alzheimer’s Disease, a 12-week randomised placebo-controlled trial in 44 older adults with cognitive impairment that reported significant cognitive improvements. The trial was funded by Neurocentria, Inc. (the company developing MMFS-01, the L-threonate product), and the lead author is affiliated with that company — a clear financial conflict of interest that the authors disclose. A small Chinese trial in healthy adults (Zhang et al. 2022, PMID 36558392) reported memory improvements over 30 days. Independent replications in older adults are limited. L-threonate is not a “memory pill”; the evidence is real but early and dominated by industry-sponsored work.

Sulfate (Epsom salts) — used topically (bath salts) and orally as a saline laxative; not used as an oral magnesium supplement for nutritional purposes. There is no published evidence that magnesium absorbs through intact skin in clinically meaningful amounts. If you enjoy an Epsom-salt bath, that’s fine — it is just not a magnesium supplement.

What the head-to-head bioavailability data actually shows

Three studies anchor most of the published comparisons:

Lindberg 1990 (J Am Coll Nutr) — citrate more soluble and more bioavailable than oxide on urinary excretion in healthy volunteers.
Firoz & Graber 2001 (Magnes Res) — oxide ~4% fractional absorption; chloride, lactate, and aspartate “significantly higher and equivalent” to one another.
Walker 2003 (Magnes Res) — randomised double-blind comparison of citrate, oxide, and an amino-acid chelate at 300 mg elemental magnesium per day for 60 days; citrate the most bioavailable on 24-hour urinary magnesium.

The honest summary: organic-acid forms (citrate, lactate, aspartate) and chelated forms (bisglycinate, malate, taurate) cluster together as well-absorbed; oxide sits clearly below them. Within the well-absorbed group, head-to-head data is too thin to crown a single winner — preference comes down to bowel tolerance, price per gram of elemental magnesium, and what your label actually declares.

An important caveat: most of these trials measure surrogate markers (urinary excretion, serum magnesium) rather than hard clinical outcomes. A 2× difference in absorption does not automatically translate into a 2× difference in any health endpoint. For someone whose dietary intake is already close to the RNI, the marginal gain from a more-absorbable form is genuinely small.

The “magnesium for sleep” claim — what’s real, what isn’t

“Magnesium glycinate for sleep” has become one of the most-marketed wellness claims of the last few years. The evidence underneath it is more modest than the marketing.

The strongest single piece of consumer-relevant evidence is the Mah & Pitre 2021 meta-analysis, which pooled three randomised trials of oral magnesium in older adults with insomnia (151 participants in total). The pooled result was a roughly 17-minute reduction in time-to-fall-asleep versus placebo, with no statistically significant change in total sleep duration. The authors graded the evidence as low quality and explicitly cautioned that the literature is “substandard” for confident clinical recommendations. The Abbasi 2012 trial included in that pool used 500 mg/day of elemental magnesium for 8 weeks — a higher dose than typical UK supplemental practice and well above the EU SCF supplemental upper limit of 250 mg/day.

Honest framing: if you are already low in magnesium, topping up to the RNI may improve sleep through restoring adequacy — magnesium gates the NMDA receptor and is required for normal nervous-system function (a GB-authorised claim). If you already meet the RNI from food, a sleep effect from supplementing further is unlikely to be large. There is no GB-authorised health claim that magnesium “aids sleep” or “promotes sleep” — that wording on a UK label would be unauthorised.

If sleep is the reason you are reaching for magnesium, sleep-hygiene basics (consistent bedtime, light exposure in the morning, late-evening caffeine and alcohol cut-offs) have stronger evidence than any supplement, and persistent insomnia is worth discussing with your GP rather than self-treating from the supplement aisle.

What UK shoppers should actually optimise for

Total elemental magnesium per day, not headline compound milligrams. A well-made label will state both. If only the compound is listed, divide by the rough elemental percentages above to estimate the actual delivered dose.
Stay inside UK reference values. The NHS RNI is 300 mg/day (men) and 270 mg/day (women) including food. The EU SCF supplemental upper limit is 250 mg/day from supplements alone (food is separate). Most well-designed UK products land at 200–400 mg elemental magnesium per serving.
Pick a form your gut tolerates. If citrate gives you loose stools, bisglycinate or malate are the obvious switches at the same elemental dose. If you don’t notice any GI effect, citrate is the cheapest well-absorbed option.
Read the supporting information. A label that names the form, declares the elemental amount, and shows GMP-certified manufacture is doing more to demonstrate quality than any star-rating or “billions of mg” headline.
Don’t pay for L-threonate as a memory pill. The human evidence is small, industry-sponsored, and not specific enough to support cognitive-enhancement claims. If you want it for general magnesium supplementation, you are paying a premium for an 8% elemental compound.

What the GB Nutrition and Health Claims Register actually allows

In regulatory terms, the only health claims a UK seller is allowed to make about magnesium are those listed on the GB Nutrition and Health Claims Register (verbatim, under Regulation 432/2012 retained in GB law):

Magnesium contributes to a reduction of tiredness and fatigue.
Magnesium contributes to electrolyte balance.
Magnesium contributes to normal energy-yielding metabolism.
Magnesium contributes to normal functioning of the nervous system.
Magnesium contributes to normal muscle function.
Magnesium contributes to normal protein synthesis.
Magnesium contributes to normal psychological function.
Magnesium contributes to the maintenance of normal bones.
Magnesium contributes to the maintenance of normal teeth.
Magnesium has a role in the process of cell division.

Anything stronger than these wordings — for example, “cures cramps”, “treats migraines”, “reduces anxiety”, “promotes sleep”, “boosts athletic performance”, “improves memory” — is not authorised in the UK and crosses from food-supplement framing into medicinal-claim territory. The Advertising Standards Authority has upheld complaints against magnesium products marketed for anxiety on exactly these grounds.

Talk to your pharmacist or GP if

You have severe kidney disease (CKD stage 4 or 5) — magnesium clearance depends on healthy kidneys.
You take a tetracycline or quinolone antibiotic, levothyroxine, or a bisphosphonate — magnesium chelates them and reduces absorption. Separate doses by 2 hours (4 hours for levothyroxine, per BNF Appendix 1).
You take long-term proton-pump inhibitors (PPIs) — magnesium status can drift low over years (MHRA Drug Safety Update 2012).
You have heart failure and take a diuretic — magnesium status interacts with both diuretics and digoxin tolerance.
You are pregnant, breastfeeding, or thinking of becoming pregnant — the NHS RNI is not raised in pregnancy and supplementation at typical food-supplement doses is generally regarded as safe, but discuss with your midwife or GP.

Suspected side effects from any supplement can be reported via the MHRA Yellow Card scheme.

Sources and further reading

Camden Medicals editorial. Information, not medical advice. Talk to your pharmacist or GP before starting any supplement, especially if you take prescribed medicines, are pregnant or breastfeeding, or have an existing condition. Suspected side effects can be reported to the MHRA via the Yellow Card scheme.

Magnesium Glycinate vs Citrate vs Oxide: Which Form Actually Does What

What “elemental magnesium” actually means